NIDC News

Our NIDC News reports the latest developments in U.S. Department of Energy’s isotope production efforts, university partnerships, facility improvements, staff news, and other notable center activities as they occur. Stay Connected

 

DOE IP and NIDC Virtual Meetings
Usually held during the SNMMI Annual Meeting, the DOE IP will now be conducting virtual "one-on-one" stakeholder meetings June 15–17, 2020. These meetings offer a great opportunity for the isotope community to personally discuss a variety of topics such as isotope supply and demand issues with the DOE IP director, DOE program managers, and the NIDC staff. The deadline to schedule a…
NIDC Spring 2020 Newsletter
The latest issue of the NIDC Newsletter is now available. Read about the latest developments in the U.S. Department of Energy Isotope Program's production, university partnerships, facility improvements, staff news, and other program activities. Highlights for this issue include: The re-establishment of domestically produced americium-241 New Product: Copper-67 routine…
The NIDC is Hiring!
The NIDC is actively searching for a new Quality Assurance & Regulatory Affairs - Senior Technical Staff Member to join our team. Located at Oak Ridge National Laboratory in Tennessee, the NIDC interfaces directly with the isotope user community and coordinates isotope production across numerous program facilities for the DOE Isotope Program. The Quality Assurance & Regulatory Affairs…
Image of COVID-19 Virus
Isotope Production classified ESSENTIAL FUNCTION at DOE National Laboratories and associated activities are being maintained Currently, all DOE IP and NIDC operations are proceeding with no interruptions to customer orders. All operations are implementing CDC advised precautions to avoid spreading the COVID-19 virus. Staff are practicing social distancing, cleaning and disinfecting…
Actinium-225 DMF Accepted by the FDA
The DOE Isotope Program (DOE IP) is pleased to announce that the U.S. Food and Drug Administration (FDA) has accepted its Type II Drug Master File (DMF) submission for Actinium-225 Nitrate (Accelerator-Produced). The alpha-emitting radionuclide and its decay product bismuth-213 (Bi-213), from an Ac-225/Bi-213 generator, have gained considerable interest within the medical community for…
NIDC Annual Customer Survey
The NIDC, on behalf of the DOE Isotope Program, seeks input from the community on anticipated isotope product needs and potential supply shortages in the next five years. With this valuable information, the DOE IP will gain a clearer understanding of future market demand and, as a result, can better serve industrial and research entities by tailoring isotope production to meet their expressed…
DOE Isotope Program Medical Isotope Production Video
Take a behind-the-scenes look at our production of medical isotopes, critical to providing diagnostic and therapeutic products for the medical community. View Video  
(From left) Rebecca Abergel, Abel Ricano, and Gauthier Deblonde of Berkeley Lab’s Chemical Sciences Division have pioneered a faster method of purifying elements. (Credit: Marilyn Chung/Berkeley Lab)
The actinides – those chemical elements on the bottom row of the periodic table – are used in applications ranging from medical treatments to space exploration to nuclear energy production. But purifying the target element so it can be used, by separating out contaminants and other elements, can be difficult and time-consuming. Now researchers at the Department of Energy’s Lawrence Berkeley…
Nuclide Chart
Recently the National Nuclear Data Center (NNDC), managed by the U.S. Department of Energy Office of Science for Nuclear Physics, updated the half-life value of actinium-225 (Ac-225) to 9.92 days. This is a change from the previously used value of 10.0 days. This update was made based on a paper published in Applied Radiation and Isotopes titled "Measurement of the Ac-225…
Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.
Recycled medical devices, diverted from going to a special landfill, supply the key ingredient in a drug that treats prostate cancer. Researchers at Oak Ridge National Laboratory have developed and demonstrated a process to produce actinium-227 using harvested radium-226 from legacy medical devices. The devices are secured by the Department of Energy Isotope Program. Scientists convert the…